Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Xuqing Shi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0008-9061-5442; OpenAlex author ID A5020361914, A5140634526. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2025: 1 paper · 2026: 2 papers

Papers 3

  1. Tumor-Derived LAMB3 Drives Immunosuppressive LRRC15+ Fibroblast Formation During Pancreatic Ductal Adenocarcinoma Development. Co-author DOI 10.1002/advs.202520029↗
  2. ALKBH5 in Cancer-Associated Fibroblasts Governs an Epitranscriptomic Axis That Drives Pancreatic Cancer Metastasis. Co-author DOI 10.1158/0008-5472.can-25-2950↗
  3. WFDC3 identified as a prognostic and immune biomarker in pancreatic cancer. First author DOI 10.17305/bb.2025.12444↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huanwen Wu · 3 shared papers, 2025–2026 · strength 0.76
  2. Zhiyong Liang · 3 shared papers, 2025–2026 · strength 0.76
  3. Bohan Liu · 2 shared papers, 2025–2026 · strength 0.54
  4. Xiaoding Liu · 2 shared papers, 2026 · strength 0.43
  5. Hangqi Liu · 1 shared paper, 2026 · strength 0.22
  6. Qixian Liu · 1 shared paper, 2026 · strength 0.22
  7. Junliang Lu · 1 shared paper, 2026 · strength 0.22
  8. Xianglin Yin · 1 shared paper, 2026 · strength 0.22
  9. Menghua Dai · 1 shared paper, 2026 · strength 0.22
  10. Lin Yang · 1 shared paper, 2026 · strength 0.22
  11. Wei‐Min Tong · 1 shared paper, 2026 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.